drugset / Trial / NCT00295022

Compare the Efficacy of Levocetirizine and Montelukast to Placebo in Reducing Seasonal Allergic Rhinitis (SAR) Symptoms in Ragweed Sensitive Subjects

NCT00295022

Phase 4 Completed 418 enrolled UCB Pharma
RandomizedParallel-groupQuadruple-blindTreatment

Summary

To compare the clinical efficacy of levocetirizine 5 mg and montelukast 10 mg on symptoms of seasonal allergic rhinitis occurring in subjects exposed to ragweed pollen in an environmental exposure unit.

Timeline

Start
2006-07-29
Primary completion
2006-10-01
Completion
2006-10-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Levocetirizine Unknown 5 mg Oral
Subject Montelukast Other / unclassified 10 mg Oral